FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2898863057> ?p ?o ?g. }

• W2898863057 endingPage "80" @default.
• W2898863057 startingPage "72" @default.
• W2898863057 abstract "Nanoparticles (NPs)-based vaccine delivery systems are widely used for their ability to control the release of antigens and promote immune responses against cancer or infectious diseases. In this study, the immunopotentiator Angelica sinensis polysaccharide (ASP) and model protein antigen ovalbumin (OVA) were encapsulated into Poly(lactic-co-glycolic acid) (PLGA) to formulate the novel NPs-based vaccine delivery system (ASP-PLGA/OVA). These formulations were subcutaneously administered to mice, then the magnitude and kinetics of antibody and cellular immune responses were assessed. The ASP-PLGA/OVA NPs were pherical in shape with smooth surfaces, approximately 225.2 nm in average size, negatively charged (around −11.27 mV), and the encapsulation efficiency of OVA at around 66.28%, respectively. Furthermore, ASP-PLGA/OVA NPs could keep stable at 4 °C over 30 days and provide a sustained and controlled release of OVA from the NPs. The results demonstrated that mice immunized with ASP-PLGA/OVA NPs could significantly enhance lymphocyte proliferation and improve the ratio of CD4+ to CD8+ T cells, thereby ASP-PLGA/OVA NPs could induce a strong cellular immune response. Moreover, the ASP-PLGA/OVA NPs could induce vigorous and long-term IgG immune responses with a mixed Th1 and Th2 responses and up-regulate the levels of Th-associated cytokines. These results suggested that ASP-PLGA/OVA NPs, which stimulated strong and continuous antibody responses and induced cellular immune responses, could potentially serve as an efficient and safe vaccine delivery and adjuvant system against infections and diseases." @default.
• W2898863057 created "2018-11-09" @default.
• W2898863057 creator A5002134783 @default.
• W2898863057 creator A5023573723 @default.
• W2898863057 creator A5034524175 @default.
• W2898863057 creator A5042413260 @default.
• W2898863057 creator A5043258862 @default.
• W2898863057 creator A5046463494 @default.
• W2898863057 creator A5067341225 @default.
• W2898863057 creator A5089273861 @default.
• W2898863057 date "2019-01-01" @default.
• W2898863057 modified "2023-09-30" @default.
• W2898863057 title "Angelica sinensis polysaccharide encapsulated into PLGA nanoparticles as a vaccine delivery and adjuvant system for ovalbumin to promote immune responses" @default.
• W2898863057 cites W1539484437 @default.
• W2898863057 cites W1977081616 @default.
• W2898863057 cites W1980212124 @default.
• W2898863057 cites W1985786449 @default.
• W2898863057 cites W2017963564 @default.
• W2898863057 cites W2019921081 @default.
• W2898863057 cites W2024241172 @default.
• W2898863057 cites W2025990308 @default.
• W2898863057 cites W2033939437 @default.
• W2898863057 cites W2034041655 @default.
• W2898863057 cites W2042791775 @default.
• W2898863057 cites W2043390251 @default.
• W2898863057 cites W2058791488 @default.
• W2898863057 cites W2067496698 @default.
• W2898863057 cites W2070661869 @default.
• W2898863057 cites W2073974110 @default.
• W2898863057 cites W2092816902 @default.
• W2898863057 cites W2107215997 @default.
• W2898863057 cites W2113271503 @default.
• W2898863057 cites W2118965097 @default.
• W2898863057 cites W2122309310 @default.
• W2898863057 cites W2135221251 @default.
• W2898863057 cites W2135674359 @default.
• W2898863057 cites W2196146022 @default.
• W2898863057 cites W2206989171 @default.
• W2898863057 cites W2214957293 @default.
• W2898863057 cites W2219326255 @default.
• W2898863057 cites W2235695557 @default.
• W2898863057 cites W2274149577 @default.
• W2898863057 cites W2286743662 @default.
• W2898863057 cites W2313028407 @default.
• W2898863057 cites W2319815424 @default.
• W2898863057 cites W2331675415 @default.
• W2898863057 cites W2407547125 @default.
• W2898863057 cites W2410308228 @default.
• W2898863057 cites W2610639910 @default.
• W2898863057 cites W2612882439 @default.
• W2898863057 cites W2746040557 @default.
• W2898863057 cites W2752904340 @default.
• W2898863057 doi "https://doi.org/10.1016/j.ijpharm.2018.11.008" @default.
• W2898863057 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30399435" @default.
• W2898863057 hasPublicationYear "2019" @default.
• W2898863057 type Work @default.
• W2898863057 sameAs 2898863057 @default.
• W2898863057 citedByCount "42" @default.
• W2898863057 countsByYear W28988630572019 @default.
• W2898863057 countsByYear W28988630572020 @default.
• W2898863057 countsByYear W28988630572021 @default.
• W2898863057 countsByYear W28988630572022 @default.
• W2898863057 countsByYear W28988630572023 @default.
• W2898863057 crossrefType "journal-article" @default.
• W2898863057 hasAuthorship W2898863057A5002134783 @default.
• W2898863057 hasAuthorship W2898863057A5023573723 @default.
• W2898863057 hasAuthorship W2898863057A5034524175 @default.
• W2898863057 hasAuthorship W2898863057A5042413260 @default.
• W2898863057 hasAuthorship W2898863057A5043258862 @default.
• W2898863057 hasAuthorship W2898863057A5046463494 @default.
• W2898863057 hasAuthorship W2898863057A5067341225 @default.
• W2898863057 hasAuthorship W2898863057A5089273861 @default.
• W2898863057 hasConcept C147483822 @default.
• W2898863057 hasConcept C159654299 @default.
• W2898863057 hasConcept C185592680 @default.
• W2898863057 hasConcept C202751555 @default.
• W2898863057 hasConcept C203014093 @default.
• W2898863057 hasConcept C2776946954 @default.
• W2898863057 hasConcept C2777863537 @default.
• W2898863057 hasConcept C2780165375 @default.
• W2898863057 hasConcept C2911179620 @default.
• W2898863057 hasConcept C55493867 @default.
• W2898863057 hasConcept C86803240 @default.
• W2898863057 hasConcept C8891405 @default.
• W2898863057 hasConceptScore W2898863057C147483822 @default.
• W2898863057 hasConceptScore W2898863057C159654299 @default.
• W2898863057 hasConceptScore W2898863057C185592680 @default.
• W2898863057 hasConceptScore W2898863057C202751555 @default.
• W2898863057 hasConceptScore W2898863057C203014093 @default.
• W2898863057 hasConceptScore W2898863057C2776946954 @default.
• W2898863057 hasConceptScore W2898863057C2777863537 @default.
• W2898863057 hasConceptScore W2898863057C2780165375 @default.
• W2898863057 hasConceptScore W2898863057C2911179620 @default.
• W2898863057 hasConceptScore W2898863057C55493867 @default.
• W2898863057 hasConceptScore W2898863057C86803240 @default.
• W2898863057 hasConceptScore W2898863057C8891405 @default.
• W2898863057 hasFunder F4320321001 @default.
• W2898863057 hasFunder F4320335787 @default.

• next